(MWOE) Amundi MSCI World DR USD EUR - Ratings and Ratios
Stocks, Technology, Healthcare, Industrials, Consumer
Description: MWOE Amundi MSCI World DR USD EUR
The Amundi MSCI World UCITS ETF DR USD Inc EUR is a Global Large-Cap Blend Equity ETF listed on XETRA, providing diversified exposure to a broad range of large-cap stocks across developed markets worldwide. Its investment objective is to track the performance of the MSCI World Index, which comprises stocks from 23 developed countries.
Key Performance Indicators (KPIs) for this ETF include its tracking error, expense ratio, and dividend yield. A low tracking error indicates that the ETF is effectively replicating the performance of its underlying index. The expense ratio, which is likely to be relatively low for a passive ETF, has a significant impact on long-term returns. The dividend yield, influenced by the dividend policies of constituent stocks, is an essential metric for income-focused investors.
The ETFs performance is driven by key economic factors, including global GDP growth, interest rates, and corporate earnings. As a Global Large-Cap Blend Equity ETF, it is sensitive to macroeconomic trends, such as changes in trade policies, currency fluctuations, and shifts in investor sentiment. The MSCI World Index is dominated by stocks from the US, Japan, and Europe, making it vulnerable to regional economic downturns.
To evaluate the ETFs potential, investors should consider its ability to provide diversified exposure, its cost-effectiveness, and its tracking performance. With an AUM of 1328.57M EUR, the ETF benefits from economies of scale, which can lead to lower expense ratios and improved liquidity. Its liquidity, as indicated by an average trading volume of 34428, is sufficient to support active trading strategies.
Investors should monitor the ETFs performance relative to its benchmark, as well as its peer group, to assess its effectiveness in achieving its investment objective. By analyzing the ETFs underlying index, investors can gain insights into the macroeconomic and market trends driving its performance.
MWOE ETF Overview
Market Cap in USD | 1,652m |
Category | Global Large-Cap Blend Equity |
IPO / Inception | 2022-06-09 |
MWOE ETF Ratings
Growth Rating | 54.2% |
Fundamental | - |
Dividend Rating | 53.3% |
Return 12m vs S&P 500 | -5.91% |
Analyst Rating | - |
MWOE Dividends
Dividend Yield 12m | 1.27% |
Yield on Cost 5y | 1.93% |
Annual Growth 5y | 61.43% |
Payout Consistency | 100.0% |
Payout Ratio | % |
MWOE Growth Ratios
Growth Correlation 3m | 93.7% |
Growth Correlation 12m | 8.2% |
Growth Correlation 5y | 93.2% |
CAGR 5y | 15.13% |
CAGR/Max DD 3y | 0.69 |
CAGR/Mean DD 3y | 9.83 |
Sharpe Ratio 12m | 1.17 |
Alpha | 0.00 |
Beta | 0.832 |
Volatility | 9.95% |
Current Volume | 28k |
Average Volume 20d | 20.2k |
Stop Loss | 13 (-3.3%) |
Signal | -1.41 |
What is the price of MWOE shares?
Over the past week, the price has changed by +0.46%, over one month by +0.94%, over three months by +6.07% and over the past year by +11.71%.
Is Amundi MSCI World DR USD EUR a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MWOE is around 15.41 EUR . This means that MWOE is currently undervalued and has a potential upside of +14.57% (Margin of Safety).
Is MWOE a buy, sell or hold?
What are the forecasts/targets for the MWOE price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 17.3 | 28.4% |
MWOE Fundamental Data Overview
Market Cap EUR = 1.41b (1.41b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.41b EUR (1.41b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.41b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.41b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.41b)/V(0.0) * Re(9.08%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 9.08% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)